Li‐Teh Liu
Impact in
- Pharmacology top 5%
- Flavonoids in Medical Research
Papers in
-
- Viral Infections and Vectors 11
- SARS-CoV-2 and COVID-19 Research 6
- SARS-CoV-2 detection and testing 3
- Viral Infections and Outbreaks Research 3
-
- Mosquito-borne diseases and control 15
- Malaria Research and Control 6
- Co-authors
- Den‐En Shieh (2 shared papers)Lien‐Chai Chiang (5 shared papers)C.C. Lin (1 shared paper)Wen‐Chun Hung (6 shared papers)Hui‐Chiu Chang (6 shared papers)Chun‐Ching Lin (3 shared papers)Jih‐Jin Tsai (25 shared papers)Lean Teik Ng (1 shared paper)
- Journals
- PLoS ONE (6 papers)Journal of Infection and Public Health (3 papers)Journal of Biomedical Science (2 papers)Frontiers in Medicine (2 papers)Oncogene (2 papers)
- Partner nations
- TaiwanUnited StatesRussia
In The Last Decade
Li‐Teh Liu
38 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 106
- Pharmacology 250
- Pharmacology 127
- Complementary and alternative medicine 95
- Cancer Research 128
- Infectious Diseases 155
Countries citing papers authored by Li‐Teh Liu
This map shows the geographic impact of Li‐Teh Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li‐Teh Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li‐Teh Liu more than expected).
Fields of papers citing papers by Li‐Teh Liu
This network shows the impact of papers produced by Li‐Teh Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li‐Teh Liu. The network helps show where Li‐Teh Liu may publish in the future.
Co-authors
The 25 scholars most cited alongside Li‐Teh Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Antioxidant and free radical scavenging effects of baicalein, baicalin and wogonin. | 2000 | 306 |
| 2 | Histone deacetylase inhibitor up-regulates RECK to inhibit MMP-2 activation and cancer cell invasion. | 2003 | 177 |
| 3 | 2003 | 125 | |
| 4 | 2001 | 116 | |
| 5 | 2002 | 97 | |
| 6 | 2003 | 60 | |
| 7 | 2003 | 55 | |
| 8 | 2002 | 28 | |
| 9 | 2018 | 27 | |
| 10 | 2011 | 24 | |
| 11 | 2013 | 23 | |
| 12 | 2018 | 22 | |
| 13 | 2019 | 21 | |
| 14 | 2018 | 21 | |
| 15 | 2022 | 18 | |
| 16 | 2013 | 17 | |
| 17 | 2020 | 16 | |
| 18 | 2019 | 14 | |
| 19 | 2023 | 12 | |
| 20 | 2003 | 12 |
About Li‐Teh Liu
Li‐Teh Liu is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health, Molecular Biology, Cancer Research and Physiology, having authored 40 papers that have together received 1.3k indexed citations. Recurring topics across this work include Mosquito-borne diseases and control (15 papers), Viral Infections and Vectors (11 papers), Malaria Research and Control (6 papers), SARS-CoV-2 and COVID-19 Research (6 papers), Protease and Inhibitor Mechanisms (4 papers), SARS-CoV-2 detection and testing (3 papers), Histone Deacetylase Inhibitors Research (3 papers) and Viral Infections and Outbreaks Research (3 papers). The work is most often cited by research in Pharmacology (250 citations), Pharmacology (127 citations), Complementary and alternative medicine (95 citations), Cancer Research (128 citations) and Infectious Diseases (155 citations). Li‐Teh Liu has collaborated with scholars based in Taiwan, United States and Russia. Frequent co-authors include Den‐En Shieh, Lien‐Chai Chiang, C.C. Lin, Wen‐Chun Hung, Hui‐Chiu Chang, Chun‐Ching Lin, Jih‐Jin Tsai, Lean Teik Ng, Liang Lin and Jung‐San Chang. Their work appears in journals such as PLoS ONE, Journal of Infection and Public Health, Journal of Biomedical Science, Frontiers in Medicine and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.